勝利精密(002426.SZ)第三季度預虧2996.6萬-3146.6萬元 同比盈轉虧
格隆匯10月14日丨勝利精密(002426.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨利潤350萬元-500萬元,同比下降99.18%-99.42%;其中,第三季度歸屬於上市公司股東的淨虧損2996.6萬元-3146.6萬元,上年同期盈利3989.34萬元。
公司2021年前三季度業績較去年同期下降的主要原因是去年同期利潤中包含處置子公司的投資收益4.87億。目前因公司外銷收入佔總收入約70%以上且外銷業務主要以美元結算,受人民幣對美元升值影響,外銷收入按即期匯率折算的人民幣金額,與按去年同期匯率折算的人民幣金額相比下降,對報吿期內業績造成一定影響;此外,受報吿期內產品主要原材料價格上漲的影響,公司營業成本有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.